Connect your AI

Immunoprecise Antibodies HYFT Q1 2025 earnings

Reported March 28, 2025 · Before market open

Revenue$4.2MMiss by $3.7M Diluted EPS-$0.06In line

Revenue estimate$7.9M

EPS estimate-$0.06

Next report

Jul 23, 2026 (in a month)

Revenue estimate$3.2M

EPS estimate-$0.05

Versus estimates

Revenue

Q1 2026$3.1MMiss by $330.2K Q4 2025$3.0MMiss by $367.5K Q3 2025$2.3MMiss by $5.0M Q2 2025$5.1MMiss by $1.3M

Q1 2025$4.2MMiss by $3.7M

Q4 2024$4.4MMiss by $2.6M

Diluted EPS

Q1 2026-$0.06Miss by $0.02 Q4 2025-$0.05Miss by $0.01 Q3 2025-$0.07Miss by $0.03 Q2 2025-$0.04Miss by $0.02

Q1 2025-$0.06In line

Q4 2024-$0.09In line

Ask the moment Immunoprecise Antibodies reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk

Questions, answered.

When did Immunoprecise Antibodies report Q1 2025 earnings?: Immunoprecise Antibodies (HYFT) reported Q1 2025 earnings on March 28, 2025 before market open.
What were Immunoprecise Antibodies's Q1 2025 revenue and EPS?: Immunoprecise Antibodies reported revenue of $4.2M and diluted EPS of $-0.06 for Q1 2025.
Did Immunoprecise Antibodies beat estimates in Q1 2025?: Revenue missed the consensus estimate of $7.9M by $3.7M. EPS beat the consensus estimate of $-0.06 by $0.00.